Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension

BACKGROUND: Recent studies have revealed that sustained ingestion of angiotensin converting enzymes inhibitors or angiotensin receptor blockers (ACEIs/ARBs) had no harmful effects on coronavirus disease 2019 (COVID-19) patients complicated with hypertension. AIM: To investigate the impact on COVID-1...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Clin Cases
Hlavní autoři: Tian, Ci, Li, Nan, Bai, Yi, Xiao, Han, Li, Shu, Ge, Qing-Gang, Shen, Ning, Ma, Qing-Bian
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2021
Témata:
Retrospective Cohort Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7809663/
https://ncbi.nlm.nih.gov/pubmed/33511171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v9.i1.47
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky